Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice

LA McConnachie, I Mohar, FN Hudson… - Toxicological …, 2007 - academic.oup.com
The analgesic and antipyretic drug acetaminophen (APAP) is bioactivated to the reactive
intermediate N-acetyl-p-benzoquinoneimine, which is scavenged by glutathione (GSH). APAP …

Modulating GSH synthesis using glutamate cysteine ligase transgenic and gene-targeted mice

…, S Shi, MB McGrath, LA McConnachie… - Drug metabolism …, 2008 - Taylor & Francis
Glutathione (GSH) is an important antioxidant and cofactor for glutathione S-transferase
conjugation. GSH synthesis is catalyzed by glutamate cysteine ligase (GCL), composed of …

Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook

Q Mu, J Yu, LA McConnachie, JC Kraft… - Journal of drug …, 2018 - Taylor & Francis
The concept of nanomedicine is not new. For instance, some nanocrystals and colloidal
drug molecules are marketed that improve pharmacokinetic characteristics of single-agent …

Neurotoxicity of domoic acid in cerebellar granule neurons in a genetic model of glutathione deficiency

G Giordano, CC White, LA McConnachie… - Molecular …, 2006 - ASPET
This study investigated the role of cellular antioxidant defense mechanisms in modulating
the neurotoxicity of domoic acid (DomA), by using cerebellar granule neurons (CGNs) from …

Lack of Maternal Glutamate Cysteine Ligase Modifier Subunit (Gclm) Decreases Oocyte Glutathione Concentrations and Disrupts Preimplantation Development in …

…, TJ Fielder, YD Hoang, J Lim, LA McConnachie… - …, 2011 - academic.oup.com
Glutathione (GSH) is the most abundant intracellular thiol and an important regulator of cellular
redox status. Mice that lack the modifier subunit of glutamate cysteine ligase (Gclm), the …

Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses

…, RC Fry, MR Lasarev, LA McConnachie… - Toxicological …, 2007 - academic.oup.com
Gene expression profiling is a widely used technique with data from the majority of
published microarray studies being publicly available. These data are being used for meta-analyses …

Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination …

JC Kraft, LA McConnachie, J Koehn, L Kinman… - Journal of controlled …, 2018 - Elsevier
… There is growing interest in developing long-acting (LA) antiretroviral (… Currently, intramuscular
(IM) LA cabotegravir and LA … Because LA cabotegravir and LA rilpivirine both take several …

Three HIV drugs, atazanavir, ritonavir, and tenofovir, coformulated in drug-combination nanoparticles exhibit long-acting and lymphocyte-targeting properties in …

…, LM Shireman, J Koehn, LA McConnachie… - Journal of …, 2018 - Elsevier
Drug-combination nanoparticles (DcNPs) administered subcutaneously represent a potential
long-acting lymphatic-targeting treatment for HIV infection. The DcNP containing lopinavir (…

[HTML][HTML] Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma

JC Kraft, LA McConnachie, J Koehn, L Kinman… - Aids, 2017 - journals.lww.com
Objective: The aim of the present study was to determine whether a combination of anti-HIV
drugs–tenofovir (TFV), lopinavir (LPV) and ritonavir (RTV)–in a lipid-stabilized …

Long-acting profile of 4 drugs in 1 anti-HIV nanosuspension in nonhuman primates for 5 weeks after a single subcutaneous injection

LA McConnachie, LM Kinman, J Koehn, JC Kraft… - Journal of …, 2018 - Elsevier
LA cabotegravir or LA rilpivirine in NHP and humans. This could be an advantage for our
DcNP formulation because the long duration of subtherapeutic levels of LA … more traditional LA